Cardiovascular system – no discrete molecular target defined

The classification 'Cardiovascular system – no discrete molecular target defined' is a descriptive category used in pharmacological databases, such as ChEMBL, to identify substances that exert physiological effects on the heart or vasculature without a known, specific molecular binding site (ChEMBL, 2024). This designation is typically applied to agents that produce systemic hemodynamic changes through non-specific mechanisms, including osmotic effects, changes in blood viscosity, or broad physical interactions with cellular membranes (PubChem, 2024). For example, osmotic diuretics like Mannitol are often grouped here because their primary cardiovascular impact stems from fluid shifts rather than molecular signaling (StatPearls, 2023). While these agents can be therapeutically useful for managing conditions like hypertension or edema, the absence of a discrete molecular target makes them outliers in modern drug discovery frameworks (PubMed, 2022). Consequently, their efficacy and safety are monitored through macro-level physiological biomarkers like mean arterial pressure and heart rate rather than molecular assays (NIH, 2023). This category highlights the complexity of systemic pharmacology where the 'target' is a physiological state rather than a single molecule.

Other names

Cardiovascular systemNon-specific cardiovascular targetPhysiological cardiovascular effectSystemic cardiovascular modulator

Systemic physiological modulation through non-specific physical or osmotic mechanisms rather than binding to a specific protein receptor or enzyme.